Ajooni Biotech (NSE:AJOONI) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AJOONI Ajooni Biotech Ltd NSE:AJOONI
64 GF Score
Price ₹3.86
GF Value ₹6.26
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Ajooni Biotech Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Ajooni Biotech Valuation Rank Related Terms

NSE:AJOONI
64GF Score
Ajooni Biotech Ltd NSE:AJOONI
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ajooni Biotech (NSE:AJOONI) Overvalued in 2026?

Based on GuruFocus' analysis, Ajooni Biotech stock appears to be undervalued. The current stock price of ₹3.86 is trading 38.3% below its estimated GF Value™ of ₹6.26. GuruFocus considers Ajooni Biotech to be Possible Value Trap.

Key valuation signals for NSE:AJOONI:

  • Valuation Rank:
  • GF Value™: ₹6.26 vs. price of ₹3.86 (38.3% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the NSE:AJOONI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ajooni Biotech Business Description

Address House No. 1769, Phase 3B2, Mohali, PB, IND, 160055
Ajooni Biotech Ltd is engaged in providing animal health care solutions dedicated to improving the productivity of Dairy farmers and sustainably increasing livestock yields. The company's products of cattle feed include Gold Pashu Aahar, Buff Plus, 3 Star, 4 Star, Calf Starter, & Transition Plus, and its feed supplements include Calvit, Batisa, Liv, Min, and other products. It derives majority portion of the revenue from the manufacturing of cattle feed. The company operates only in India.
64GF Score

Get the complete analysis for NSE:AJOONI

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3.86
Price
₹6.26
GF Value